Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

The California Medical Innovations Institute, Inc. · with Augusta University Medical Center · NCT05412069

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–75 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
155
US sites recruiting
1
Study start
February 15, 2023
Record last updated
October 21, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The objective is to determine the length-tension properties of the anal sphincters using Fecobionics in normal subjects and FI patients during anal distension and during simulated evacuation. Fecobionics has the consistency and shape of normal stool and can record pressures, cross-sectional area, orientation and viscoelastic properties of the anorectum and can map the geometric profiles during evacuation, and thereby provides multi-dimensional measurements of pressures, deformability, and topographic changes. Fecobionics combines several existing tests to provide novel insight into anorectal function. The purpose for the development was to overcome the technological controversies and disagreement between various tests and unphysiological test conditions. The aim was to imitate defecation as much as possible to the natural process. Fecobionics was developed to simulate stool and to provide the driving pressure and resulting deformations of stool along with a measure of an objective anorectal angle during defecation in a single examination. Fecobionics makes it possible to describe objectively, without disturbing the defecation process, the opening characteristics and pressure signatures during initial entry into the relaxing anal canal.

The overall goal is to provide mechanistic understanding of defecation in health and defecatory disorders. It exceeds previous attempts to make artificial stool for evaluation of defecation (BET and FECOM) and integrates other technologies as well. It was designed to have a consistency and deformability of Type 4 (range type 3-5) on the Bristol stool form scale. The range from types 3-5 is found in 70% of normal subjects. A major novelty is that Fecobionics measures pressures in axial direction; i.e., in the flow direction.

Being studied: Fecobionics

Conditions: Normal Subjects; Fecal Incontinence

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Subject must provide written informed consent;
  • Willing and able to undergo required study tests, surveys, and procedures;
  • Age > 18 years of age.

Exclusion Criteria

  • Female who is pregnant;
  • Prior anorectal surgery;
  • Prior bowel resection;
  • History of chronic constipation;
  • In the opinion of the investigator, the subject is not a suitable candidate for the study.

Recruiting US locations

  • Augusta University Medical Center

    Augusta, GA 30912

    Site contact: Satish Rao, MD, PhD · 7067212238 · srao@augusta.edu

Study contacts (from the official record)

  • Hans Gregersen, MD, PhD · 8582497400 · hag@giome.org
  • Satish Rao, MD, PhD · 7067212238 · srao@augusta.edu
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL… (NCT05412069) | Bored Studies